Background: A multidisciplinary task force, designated Target Zero, has developed protocols for prevention of surgical site infection (SSI) for spine surgery at our institution. The purpose of this study was to evaluate how compliance with an antibiotic bundle impacts infection incidences in pediatric spine surgery. Methods: After institutional review board approval, a consecutive series of 511 patients (517 procedures) who underwent primary spine procedures from 2008 to 2012 were retrospectively reviewed to identify patients who developed SSI. Patients were followed for a minimum of 90 days postoperatively. Compliance data were collected prospectively in 511 consecutive patients and a total of 517 procedures. Three criteria were required for antibiotic bundle compliance: appropriate antibiotics completely administered within 1 hour before incision, antibiotics appropriately redosed intraoperatively for blood loss and time, and antibiotics discontinued within 24 hours postoperatively. A multivariable logistic regression analysis was used to test the association between compliance and the development of an infection. Results: Overall antibiotic bundle compliance rate was 85%. After adjusting for risk category, estimated blood loss, and study year, the likelihood of an infection was increased in the noncompliant group compared with the compliant group (adjusted odds ratio: 3.0, 95% CI, 0.96-9.47, P = 0.0587). When expressed as the number needed to treat, strict adherence to antibiotic bundle compliance prevented 1 SSI within 90 days of surgery for every 26 patients treated with the antibiotic bundle.
S
urgical site infections (SSI) are commonly reported complications of pediatric spinal deformity surgery. Recent studies document postoperative and delayed-onset SSI rates associated with elective pediatric spinal surgery ranging from 3.7% to 8.5%. [1] [2] [3] [4] [5] [6] Patients with adolescent idiopathic scoliosis (AIS) are at lower risk than patients with neuromuscular scoliosis, with infection rates ranging from 0.1% to 1.3% in AIS and from 8.4% to 17.8% in neuromuscular scoliosis. 6 The development of a postoperative SSI causes tremendous burden on the health and well-being of affected children and their families. The management of infections involving instrumented fusions often requires complex treatment strategies. 7, 8 The average economic burden of treating an implant-associated spinal SSI has been reported to be $154,537, ranging from $26,977 to $961,722. Infection-related treatment has been reported to add 29 hospital admission days to a patient's care. 9 Our institution implemented a multidisciplinary infection task force in July 2007 to address these issues. Designated Target Zero (TZ), this task force consists of representatives from the departments of orthopaedic surgery, infectious disease, epidemiology, pharmacy, anesthesiology, quality improvement, and the operating room. Protocols include preoperative, intraoperative, and postoperative initiatives to address potentially modifiable risk factors for SSI. 2, 3, 5, [10] [11] [12] Methods of surveillance and formative evaluation have included monthly multidisciplinary meetings to improve compliance (Appendix A, Supplemental Digital Content 1, http://links.lww. com/BPO/A66).
Previous investigations from our institution have demonstrated that the TZ protocols result in a clinically meaningful reduction in infection rates. 13 The purpose of this study was to evaluate how compliance with the TZ perioperative antibiotic protocol impacted infection rates in both low-risk (LR) and high-risk (HR) patients undergoing spinal surgery at a tertiary pediatric hospital. We hypothesized that compliance with the antibiotic protocol would lead to reduced SSI in pediatric patients undergoing spine surgery.
METHODS
This study was performed with institutional review board approval. A retrospective chart review was used to collect demographic and clinical data on a consecutive series of 678 patients who underwent spine surgery at a single tertiary pediatric hospital between January 1, 2008 and June 30, 2012. Included in the study were patients undergoing index or revision posterior spine fusion with a minimum 90-day follow-up. Expansion of nonfusion constructs for early-onset scoliosis, implant removals, anterior spinal fusions, growing rod implants, and any other spinal procedures were excluded from the data analysis. A total of 511 patients were included based on the criteria above. Six patients underwent surgery twice within this time frame, making the total procedures 517. One patient was excluded due to lack of available compliance data (Fig. 1) . A power analysis was not performed before data collection.
The following variables were collected and assessed: demographics, diagnosis, risk category (HR or LR), type of surgery, length of fusion, leading surgeon, operative time, incidence and amount of intraoperative and postoperative transfusions, compliance with the institution's infection protocol guidelines, infection within 90 days of surgery, infection type (deep or superficial), time to infection, return to operating room for incision and drainage, infecting organism, antibiotic treatment, and total follow-up from surgery to last clinical visit. The definitions of HR and LR in this study were based on recently published best practice guidelines. 7 LR was defined as a primary fusion in a patient with AIS without significant comorbidities, whereas all other patients were classified as HR. The development of a deep SSI was the primary outcome variable of interest.
The Center for Disease Control (CDC)-National Healthcare Safety Network (NHSN)'s definition of a deep SSI was used, which is any infection that appears to be related to surgery, involves tissues and spaces at or beneath the facial layer, and exhibits at least one of the following: purulent drainage from the site, wound dehiscence, or evidence of infection found by direct examination or by histopathologic or radiographic examination. [14] [15] [16] All patients were monitored for SSI for 90 days postoperatively based on the most recent CDC definition of a deep SSI.
With implementation of TZ, standardized algorithms for surgical antibiotic prophylaxis have been developed for both LR and HR patient groups (Appendices B, Supplemental Digital Content 2, http:// links.lww.com/BPO/A67 and C, Supplemental Digital Content 3, http://links.lww.com/BPO/A68). These algorithms guide practitioners in selecting the appropriate perioperative antibiotics based on patient age, risk category, and presence or absence of methicillin-resistant Staphylococcus aureus on preoperative testing by nasal swab, while also guiding dosing regimens both intraoperatively and postoperatively. Our institution's antibiotic dosing regimens are largely based on American Society of Health-System Pharmacist recommendations. 17 A perioperative antibiotic bundle was created by a multidisciplinary team of specialists at our institution, and compliance with this TZ antibiotic bundle has been measured through prospective data collection. Successful antibiotic bundle compliance required all 3 of the following: (1) appropriate IV antibiotics completely administered within 1 hour before incision, (2) IV antibiotics appropriately redosed intraoperatively for blood loss and surgical time, and (3) IV antibiotics discontinued within 24 hours postoperatively.
Statistical Methods
Descriptive statistics were used to summarize the demographics and clinical characteristics of all subjects included in the 2 cohorts. The w 2 test, Student t test, or Wilcoxon rank-sum test, when appropriate, were used to compare the demographics and clinical characteristics in the 2 groups. On the basis of this analysis and previous studies, study year, risk status, levels fused, operative time, and estimated blood loss were considered as potential confounding variables. A degree of correlation was noted between the intraoperative variables of levels fused, operative time, and estimated blood loss. From this group of related variables, we elected to include estimated blood loss in subsequent statistical analyses as this variable was clearly related to the compliance protocol (redosing after intraoperative transfusion was included in the antibiotic protocol) and is known to increase risk of infections (outcome variable). A multivariable logistic regression analysis was used to test the null hypothesis of no difference in the odds of an infection in the compliant group compared with the noncompliant group. The final model included study year, risk status, estimated blood loss, and the primary exposure variable of interest, protocol compliance. On the basis of the logistic regression analysis, adjusted estimates of the absolute risk reduction and number needed to treat (NNT) were obtained using the methods described by Austin. 18 Bootstrap samples (100 iterations) were used to estimate the 95% confidence intervals (CI) for the absolute risk reduction.
RESULTS
Complete data were available for 517 procedures (511 patients) with at least 90 days of follow-up. The 2 groups were similar with respect to surgery year, study quarter, sex, surgical intervention, diagnosis, and body mass index. There was a significant difference in the distribution of protocol compliance with respect to study year, levels fused, operative time, and estimated blood loss ( Table 1 ). The overall TZ antibiotic bundle compliance rate was 84.9% (439/517). The occurrence of noncompliance was 10.3% (53/517) for bundle component 1 (failure to infuse preoperative antibiotics 1 h before incision), 5.5% (23/517) for bundle component 2 (failure to redose antibiotics intraoperatively based on time or blood loss), and 1.9% (10/517) for bundle component 3 (failure to discontinue antibiotics within 24 h postoperatively). Among the noncompliant subjects, 8 were noncompliant with respect to multiple bundle components ( Table 2) .
The cumulative incidence of SSI in the first 90 days after surgery was 3.1% (95% CI, 1.6-5%). To estimate the independent effect of protocol compliance on the likelihood of compliance, we adjusted for estimated blood loss (adjusted odds of infection for every 1 mL increase in blood loss: 1.0, 95% CI, 0.9-1.0, P = 0.8247), risk category (odds of infection HR vs. LR: 2.8, 95% CI, 0.9-9.3, P = 0.0849), and surgical year (odds of infection first study year after implementation of the compliance bundle vs. last full year of study period: 0.6, 95% CI, 0.1-3.93, P = 0.2242) in the multivariable logistic regression analysis. Compliance with the antibiotic bundle was associated with reduced likelihood of developing SSI. The odds of SSI in the noncompliant group were 3.0 times (95% CI, 0.96-9.47, P = 0.0587) the odds of infection in the compliant group. We also tested the interaction between compliance and risk category. The odds of infection among compliant versus noncompliant subjects did not significantly depend on risk status (P = 0.2474). Considered in terms of the absolute risk reduction, the adjusted difference in the incidence of infection between the compliant and noncompliant groups was 3.9% (95% CI, À 1.1% to 10.0%). When expressed as the NNT, strict adherence to antibiotic bundle compliance prevented 1 SSI within 90 days of surgery for every 26 patients treated with the antibiotic bundle [NNT (benefit) = 25.6, 95% CI, NNT (harm) 84.4 to N and NNT (benefit) 10 to N]. A secondary analysis was used to describe the distribution of organisms on the basis of compliance status. MSSA was the most common organism identified in both the compliant (4/11) and noncompliant groups (4/5). To account for a potential different distribution of organisms among HR and LR patients, the distribution of organism type was stratified by risk status (Table 3 ).
DISCUSSION
Our hypothesis that compliance with the TZ perioperative antibiotic protocol would lead to decreased infection incidences in pediatric spinal surgery was confirmed. It is widely recognized that the risk of SSI can be reduced with the coordinated efforts of a multidisciplinary team. 13, 15, 19 Compliance with an institution's perioperative antibiotic prophylaxis bundle is 1 modifiable risk factor that can minimize the risk for SSI. Previous reports have detailed the challenges associated with antimicrobial SSI prophylaxis, including selection of the appropriate antibiotic, timely preoperative dosing, intraoperative redosing, and postoperative antibiotic administration. 14, 20 A related retrospective study analyzing 5309 pediatric patients in multiple subspecialty areas of pediatric surgery found a significant reduction in SSI from 4.3% to 3.0% when complete compliance with antibiotic prophylaxis was performed, resulting in a 30% decreased risk of SSI. 21 Larger studies have also shown significantly lower SSI rates across multiple surgical specialties with appropriate antibiotic selection and when antibiotic timing was improved. [22] [23] [24] Our study is the first, to our knowledge, to specifically assess the relationship between perioperative antibiotic bundle compliance and SSI in pediatric spinal surgery using prospectively collected compliance data.
The NNT in this study was 26, or simply, for every 26 patients who were treated with compliance to the antibiotic bundle, 1 SSI was prevented. This NNT value can be put into context with reference to published studies utilizing this analysis tool. A NNT of 16 has been found for prevention of early infection after open fracture when antibiotics were used versus no antibiotics or placebo. 25 We used an estimate of cumulative incidence to compare effectiveness of the compliance bundle at decreasing infection risk. Cumulative incidence, defined as the number of new cases of disease (infection) over a specific time period (first 90 days postsurgery), was compared between compliant versus noncompliant subjects.
The determination of confounding variables is challenging. It is important to remember that a variable must be related to both the outcome and the exposure, which is compliance status in this study, to be a confounding variable. We felt that it was reasonable to assume that certain demographic and clinical characteristics were not related to compliance. In order for demographic variables to be related to compliance, the providers would have to consciously or unconsciously focus on a particular demographic factor when implementing the compliance bundle. The program was inclusive, and thus we were comfortable with the assumption that all patients were treated equally. Yet, estimates were adjusted for potential confounding variables. On the basis of the comparison of demographic and clinical characteristics in the compliant versus noncompliant group, we included risk category, surgical year, and estimated blood. It should be noted that levels fused, operative time, and estimated blood loss were all significantly different between groups. To keep the model as parsimonious as possible, we only included estimated blood loss from this group of related variables. We chose estimated blood loss based on the fact that it is related to the exposure (compliance) and outcome (infection). Increased blood loss is recognized as a risk factor for development of a SSI in pediatric spine surgery. 26 Estimated blood loss is also clearly related to compliance status, as 1 component of the compliance bundle was redosing after blood transfusion. Levels fused and operative time cause blood loss which are likely to lead to noncompliance, and more specifically, failure to redose after transfusion. Further, we included estimated blood loss in the logistic regression model, and after adjusting for surgery year, compliance, and risk category, there was no association between blood loss and the likelihood of an infection (P = 0.8247).
The underlying reason for noncompliance in 8.7% out of the 15% total noncompliant subjects was that appropriate IV antibiotics were not completely administered within 1 hour before incision. Table 2 further delineates the reasons for noncompliance. The number of different combinations of compliance factors makes it too challenging to estimate the independent effect of each compliance factor on the overall incidence of SSI in a meaningful way. More importantly, we believe that compliance with all 3 components of compliance bundle is a surrogate variable for higher level of care. Providers that are more likely to be attentive to all aspects of the compliance protocol are also going to more likely to be attentive to other relevant areas of care. In this way, we felt it was best to test compliance as a composite variable. Constant feedback and multidisciplinary oversight have been shown to be essential in optimizing the TZ protocol and minimizing the risks for SSI. 27 With the creation of these feedback strategies, all noncompliant cases are reviewed at monthly meetings to address the error and encourage future compliance (Appendix A, Supplemental Digital Content 1, http://links.lww.com/ BPO/A66). When this study's time frame was broken down into quarters, no significant differences were noted with respect to compliance and study quarter, suggesting that although active efforts to improve compliance over time were made, notable changes were not shown.
There are several limitations to this study. Compliance to the perioperative antibiotic protocol was defined to require all 3 components listed, including discontinuation of antibiotics within 24 hours postoperatively. Although multiple published reports have demonstrated the importance of appropriate antibiotic choice and timing of administration in preventing SSI, the continuation of antibiotics beyond 24 hours postoperatively has not been shown to increase rates of SSI. 28 Whereas discontinuation of antibiotics may not alter infection incidences, adherence to this aspect of the protocol demonstrates an attention to detail that underscores the emphasis placed on compliance to the defined protocol and appropriately managing a patient's infection risk. As the perioperative antibiotic compliance criteria have been established by the TZ task force before development of this study, using this original definition of compliance throughout the prospective data collection was most consistent. Moreover, of the noncompliant patients, only 10% were due to continuation of antibiotics beyond 24 hours postoperatively, and when antibiotics were continued for an appropriate clinical indication such as a remaining chest tube, these instances were not recorded as noncompliant.
Another limitation in the interpretation of our results is that we changed our institutional definition for HR and LR in the beginning of 2013. As mentioned, the new definitions for HR and LR were then retroactively applied to all patients in the study, and many patients were analyzed as HR, despite not being treated at the time of surgery through our Care Pathway for HR patients. HR patients typically participated in the Care Pathway for Spinal Surgery (CAPSS), which was established by our institution as a means for facilitating a multidisciplinary approach to children with significant comorbidities, and therefore underwent significant evaluations preoperatively. 13, 19 Given that the LR group included only AIS patients without significant comorbidities, and the HR group included all others, it should be recognized that the HR group in this study likely represents a population of patients with disparate risk factors for infection, and the infection rate for HR patients with known risk factors for infection may be underreported in this study.
Through a multidisciplinary approach and previously described feedback mechanism, the evolution of TZ during the study period has included such measures as developing standardized order sets in the electronic medical record to comply with the TZ protocol, standardizing preoperative skin preparation, limiting OR traffic, and prohibiting family members from entering the operating suite during anesthesia induction. Without isolating these changing variables it is difficult to know the degree to which the factors impact SSI incidences. Also, comorbidities such as obesity, skin acne, and implant material were not controlled for in this study. No significant differences were found with either compliance rate or SSI between different surgeons, but other potential confounding factors that were not recorded may have been present such as variability in the operating room surgical team or differences in surgical techniques. In addition, it is difficult to demonstrate a direct causal relationship between adherence to the antibiotic bundle and reduction in SSI as the study was not a randomized controlled design. Moreover, the TZ protocol is constantly evolving in an effort to optimize the reduction in SSI. An illustration of the iterative process that exemplifies the TZ task force came in the summer of 2012, when topical antibiotics placed into the bone graft became part of the standardized intraoperative protocol for all patients undergoing spine surgery. As such, isolating individual variables and their correlation with SSI is challenging. This study, however, attempts to prospectively study the impact of antibiotic compliance on infection rates within the context of balancing the realtime clinical dilemmas of making continual changes that will optimize patient care.
Postoperative infections secondary to spinal surgery are economically burdensome, demand an excessive allocation of resources, and can have significant negative effects on patient outcomes while increasing hospital LOS, patient morbidity, and mortality. 9, 29 Our data demonstrated a significant decreased incidence of SSI when compliance to the TZ perioperative antibiotic protocol was met. Antibiotic compliance is merely 1 component of an effective infection prevention program, and this study underscores the importance of consistently adhering to all of the individual components of an institution's infection control program. This study shows that compliance with a comprehensive antibiotic protocol can lead to meaningful reductions in SSI incidences in pediatric spine surgery. Standardization of preoperative, intraoperative, and postoperative measures with a
